A group of scientists at UNSW Sydney have discovered that a type of bacteria known as Aeromonas are the second most prevalent bacterial pathogen found in patients with gastroenteritis.
Jun 29, 2023
0
6
The UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and fight antimicrobial resistance.
Jun 22, 2023
0
1
Entry of the SARS-CoV-2 virus into human tissues depends on the activity of a host gene that regulates production of a key viral receptor, according to a study publishing June 13 in the open access journal PLOS Biology by ...
Jun 13, 2023
0
38
While most people survive and recover from COVID, for some people symptoms can persist for months or years. When symptoms last longer than 12 weeks, the condition is known as long COVID.
Jun 9, 2023
0
8
Fungi are present on the skin of around 70% of the population, without causing harm or benefit. Some fungal infections, like athlete's foot, are minor. Others, like Candida albicans, can be deadly—especially for individuals ...
May 26, 2023
0
2
Respiratory syncytial virus (RSV) is a highly contagious and seasonal respiratory virus that mainly causes common cold symptoms in healthy adults but can cause more serious lung infections in infants, the immunocompromised ...
May 24, 2023
0
29
A new review article published in the Bosnian Journal of Basic Medical Sciences offers valuable insights into the multi-organ system damage caused by the SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic.
May 23, 2023
0
2
Smallpox viruses are notorious for their ability to remain infectious in the environment for a very long time. A study conducted by the Department of Molecular and Medical Virology at Ruhr University Bochum, Germany, has ...
May 15, 2023
0
5
Among the yeasts from the Candida genus that cause infections in humans, the species Candida auris is still relatively new: this species was only described in 2009, and to date no evidence has been found before the 1990s. ...
May 12, 2023
0
2
The first vaccine against respiratory syncytial virus (RSV) has been approved by the US Food and Drug Administration. The vaccine, named Arexvy, will be given to people 60 years and older.
May 10, 2023
0
3
